Last updated on July 2018

Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms


Brief description of study

The objective of this Post-Market Clinical Follow-up (PMCF) is to confirm the performance and safety of the Codman Enterprise 2 when used in conjunction with endovascular coil embolization of ruptured or non-ruptured intracranial aneurysms.

Clinical Study Identifier: NCT02415010

Contact Investigators or Research Sites near you

Start Over

M HARTMANN, MD-PhD

Helios Klinikum Berlin
Berlin, Germany
  Connect »

S FISCHER, MD

Universit tslklinikum der Ruhr Universit t Bochum
Bochum, Germany
  Connect »

J FIEHLER, MD-PhD

Universit tsklinikum Hamburg Eppendorf
Eppendorf, Germany
  Connect »

B ECKERT, MD-PhD

Asklepios Klinik Atona
Hamburg, Germany
  Connect »

J OLIER, MD

Hospital Universitario de Navarra
Pamplona, Spain
  Connect »

Jan Gralla, MD-PhD

Inselspital-Universit tsspital Bern
Bern, Switzerland
  Connect »

Tony GODDARD, MB PhD

Spire Leeds Hospital
Leeds, United Kingdom
  Connect »

S DERAKHSHANI, MD

Queen's Hospital of Romford
Romford, United Kingdom
  Connect »

P SCHRAMM, MD-PhD

Universit tsklinikum Schl.-Holst. Campus L beck
Lübeck, Germany
  Connect »

Zsolt Kulcsar, MD

H pitaux Universitaires de Gen ve
Genève, Switzerland
  Connect »